{"id":"https://openalex.org/W2331477959","doi":"https://doi.org/10.1021/jm401337x","title":"Imidazopyridazine Hepatitis C Virus Polymerase Inhibitors. Structure\u2013Activity Relationship Studies and the Discovery of a Novel, Traceless Prodrug Mechanism","display_name":"Imidazopyridazine Hepatitis C Virus Polymerase Inhibitors. Structure\u2013Activity Relationship Studies and the Discovery of a Novel, Traceless Prodrug Mechanism","publication_year":2013,"publication_date":"2013-11-13","ids":{"openalex":"https://openalex.org/W2331477959","doi":"https://doi.org/10.1021/jm401337x","mag":"2331477959","pmid":"https://pubmed.ncbi.nlm.nih.gov/24224729"},"language":"en","primary_location":{"id":"doi:10.1021/jm401337x","doi":"https://doi.org/10.1021/jm401337x","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm401337x","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075468060","display_name":"Martin R. Leivers","orcid":"https://orcid.org/0000-0002-0777-7491","observed_orcids":["https://orcid.org/0000-0002-0777-7491"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Martin Leivers","raw_affiliation_strings":["GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054715879","display_name":"John Fleek Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John F. Miller","raw_affiliation_strings":["GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050835009","display_name":"Stephanie A. Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie A. Chan","raw_affiliation_strings":["GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003574631","display_name":"Ryan Lauchli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Lauchli","raw_affiliation_strings":["GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070414124","display_name":"Sebastian Liehr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099140","display_name":"Santen (United States)","ror":"https://ror.org/0108v8438","country_code":"US","type":"company","lineage":["https://openalex.org/I149737975","https://openalex.org/I4210099140"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sebastian Liehr","raw_affiliation_strings":["GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","Santen Inc., 2100 Powell Street,\rSuite 1600, Emeryville, California 94608, United States","GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States; Santen Inc., 2100 Powell Street,\n"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"Santen Inc., 2100 Powell Street,\rSuite 1600, Emeryville, California 94608, United States","institution_ids":["https://openalex.org/I4210099140"]},{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States; Santen Inc., 2100 Powell Street,\n","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008323548","display_name":"Wenyan Mo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenyan Mo","raw_affiliation_strings":["ChemPartner Co., 998 Halei Road, Shanghai 201203, China","GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemPartner Co., 998 Halei Road, Shanghai 201203, China","institution_ids":[]},{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071966738","display_name":"Tony L. Ton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210151032","display_name":"Principia Biopharma (United States)","ror":"https://ror.org/05fw76c12","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151032"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tony Ton","raw_affiliation_strings":["GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","Principia Biopharma, Inc., 400\rEast Jamie Court, Suite 302, South San Francisco, California 94080, United States","GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States; Principia Biopharma, Inc., 400\n"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"Principia Biopharma, Inc., 400\rEast Jamie Court, Suite 302, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I4210151032"]},{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States; Principia Biopharma, Inc., 400\n","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007195382","display_name":"ELIZABETH M. C. TURNER","orcid":"https://orcid.org/0000-0002-4914-9477","observed_orcids":["https://orcid.org/0000-0002-4914-9477"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth M. Turner","raw_affiliation_strings":["GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075075896","display_name":"Michael Youngman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4210151493","display_name":"Lieber Institute for Brain Development","ror":"https://ror.org/04q36wn27","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151493"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Youngman","raw_affiliation_strings":["GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","Lieber Institute For Brain Development, 855 North Wolfe Street, Suite 300, Baltimore, Maryland 21205, United States","GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States; Lieber Institute For Brain Development, 855 North Wolfe Street, Suite 300, Baltimore, Maryland 21205, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"Lieber Institute For Brain Development, 855 North Wolfe Street, Suite 300, Baltimore, Maryland 21205, United States","institution_ids":["https://openalex.org/I4210151493"]},{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States; Lieber Institute For Brain Development, 855 North Wolfe Street, Suite 300, Baltimore, Maryland 21205, United States","institution_ids":["https://openalex.org/I4210151493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043229064","display_name":"James Greg Falls","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Greg Falls","raw_affiliation_strings":["GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025637474","display_name":"Susan Long","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Long","raw_affiliation_strings":["GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061355653","display_name":"Amanda Mathis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4405270783","display_name":"Salix Pharmaceuticals (United States)","ror":"https://ror.org/01akhf054","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270783"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Mathis","raw_affiliation_strings":["GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","Nonclinical\rand Clinical Pharmacology, Salix Pharmaceuticals, Inc., 8510 Colonnade\rCenter Drive, Raleigh, North\rCarolina 27615, United States","GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States; Nonclinical#R#and Clinical Pharmacology, Salix Pharmaceuticals, Inc., 8510 Colonnade#R#Center Drive, Raleigh, North#R#Carolina 27615, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"Nonclinical\rand Clinical Pharmacology, Salix Pharmaceuticals, Inc., 8510 Colonnade\rCenter Drive, Raleigh, North\rCarolina 27615, United States","institution_ids":["https://openalex.org/I4405270783"]},{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States; Nonclinical#R#and Clinical Pharmacology, Salix Pharmaceuticals, Inc., 8510 Colonnade#R#Center Drive, Raleigh, North#R#Carolina 27615, United States","institution_ids":["https://openalex.org/I4405270783"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001623764","display_name":"Jill T. Walker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jill Walker","raw_affiliation_strings":["GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5075468060"],"corresponding_institution_ids":["https://openalex.org/I4210114143"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.5615,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.72015092,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"57","issue":"5","first_page":"1964","last_page":"1975"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.7350000143051147},{"id":"https://openalex.org/keywords/ns5b-polymerase-inhibitors","display_name":"NS5B polymerase inhibitors","score":0.9679999947547913},{"id":"https://openalex.org/keywords/imidazopyridazines","display_name":"imidazopyridazines","score":0.9359999895095825},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.878000020980835},{"id":"https://openalex.org/keywords/herg-liability","display_name":"hERG liability","score":0.8679999709129333},{"id":"https://openalex.org/keywords/decarboxylation","display_name":"decarboxylation","score":0.9769999980926514},{"id":"https://openalex.org/keywords/solubility-enhancement","display_name":"solubility enhancement","score":0.7799999713897705},{"id":"https://openalex.org/keywords/chronic-toxicity","display_name":"chronic toxicity","score":0.6779999732971191},{"id":"https://openalex.org/keywords/antiviral-drug-discovery","display_name":"antiviral drug discovery","score":0.8360000252723694}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.9010035991668701},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8941540718078613},{"id":"https://openalex.org/C2779362680","wikidata":"https://www.wikidata.org/wiki/Q905000","display_name":"hERG","level":3,"score":0.8238098621368408},{"id":"https://openalex.org/C2781426373","wikidata":"https://www.wikidata.org/wiki/Q24766653","display_name":"NS5B","level":5,"score":0.6698449850082397},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.596938967704773},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.5747092366218567},{"id":"https://openalex.org/C2780595602","wikidata":"https://www.wikidata.org/wiki/Q898436","display_name":"Decarboxylation","level":3,"score":0.5338488817214966},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.532932698726654},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.5287394523620605},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5184949636459351},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.5009493827819824},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.49831461906433105},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4089750647544861},{"id":"https://openalex.org/C2781463415","wikidata":"https://www.wikidata.org/wiki/Q2082778","display_name":"Hepacivirus","level":4,"score":0.3841176927089691},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.37491047382354736},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.32613247632980347},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2772405743598938},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.26063692569732666},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.14241757988929749},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.10302361845970154},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.0},{"id":"https://openalex.org/C83743174","wikidata":"https://www.wikidata.org/wiki/Q423778","display_name":"Potassium channel","level":2,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012324","descriptor_name":"RNA-Dependent RNA Polymerase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D017361","descriptor_name":"Viral Nonstructural Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm401337x","doi":"https://doi.org/10.1021/jm401337x","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm401337x","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:24224729","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24224729","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1605498422","https://openalex.org/W1975553990","https://openalex.org/W1981008233","https://openalex.org/W1986362062","https://openalex.org/W1989521996","https://openalex.org/W1997268973","https://openalex.org/W1999007060","https://openalex.org/W2008079733","https://openalex.org/W2015216410","https://openalex.org/W2019523835","https://openalex.org/W2019915078","https://openalex.org/W2030433671","https://openalex.org/W2030542598","https://openalex.org/W2047880168","https://openalex.org/W2055533190","https://openalex.org/W2059183805","https://openalex.org/W2063338707","https://openalex.org/W2071873660","https://openalex.org/W2072225540","https://openalex.org/W2087587204","https://openalex.org/W2107713887","https://openalex.org/W2113341067","https://openalex.org/W2125958583","https://openalex.org/W2131245377","https://openalex.org/W2151898297","https://openalex.org/W2162287933"],"related_works":["https://openalex.org/W2799742983","https://openalex.org/W2328416920","https://openalex.org/W2334156852","https://openalex.org/W2335369128","https://openalex.org/W2081819500","https://openalex.org/W2079199249","https://openalex.org/W624584784","https://openalex.org/W2119499868","https://openalex.org/W1987870527","https://openalex.org/W2033008509"],"abstract_inverted_index":{"By":[0],"reducing":[1],"the":[2,5,15],"basicity":[3],"of":[4,11,58],"core":[6],"heterocycle":[7],"in":[8,26,64],"a":[9,41,50],"series":[10],"HCV":[12],"NS5B":[13],"inhibitors,":[14],"hERG":[16],"liability":[17],"was":[18,22,44,47],"reduced.":[19],"The":[20,54],"SAR":[21],"then":[23],"systematically":[24],"explored":[25],"order":[27],"to":[28],"increase":[29],"solubility":[30],"and":[31,46,56,61],"enable":[32],"dose":[33],"escalation":[34],"while":[35],"retaining":[36],"potency.":[37],"During":[38],"this":[39],"exploration,":[40],"facile":[42],"decarboxylation":[43],"noted":[45],"exploited":[48],"as":[49],"novel":[51],"prodrug":[52],"mechanism.":[53],"synthesis":[55],"characterization":[57],"these":[59],"prodrugs":[60],"their":[62],"utilization":[63],"chronic":[65],"toxicity":[66],"studies":[67],"are":[68],"presented.":[69]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}